Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2022-2028
As per Triton’s research
report, the cough syrup market in Latin America is anticipated to witness
growth at a CAGR of 2.36% during the
forecasting years 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries evaluated in the region are:
•
Brazil
•
Mexico
•
Rest of Latin America
Brazil
secures the majority of the share in the cough syrup market. In the region, upper respiratory infections,
chronic obstructive pulmonary disease, tuberculosis, and lung cancer are major
causes of mortality. COPD is rising at a rapid rate across Mexico, Brazil,
Argentina, and others. Here, tobacco has gained significant attention, leading
to a rise in COPD risk among the population. The rising prevalence of COPD and
asthma are majorly increasing the demand for cough syrups. Furthermore,
increased air pollution levels also drive the cough syrup market’s growth.
Chronic obstructive pulmonary disease is highly
prevalent in Brazil. Besides this, asthma is prevalent among children and
adolescents. These diseases are major health burdens affecting the country.
Furthermore, rapid industrialization and urbanization have increased air
pollution to a large extent, creating a high risk of contracting respiratory
diseases. These conditions are also fueled by occupational exposure. These
factors have increased the consumption rate of cough syrups over the recent
years. Therefore, the rise in respiratory conditions, increase in air
pollution, and urbanization activities are propelling the Brazilian cough syrup
market on a progressive path.
On the other hand, air pollution is a major
cause of death in Mexico. Air pollution has increased the risk of chronic lung
disease and acute respiratory infections. Hence, the rising pollution levels
have surged the demand for cough syrups, influencing the cough syrup market’s
growth.
A retail pharmacy is a major distribution
channel for companies to provide medications to people, along with health
advice. Retail pharmacies provide all types of cough syrups. Moreover, they
track customer details to track the sale of cough syrups and other medications.
Several companies such as Abbott, Novartis, and others market their products
via retail pharmacies. The cough syrup
market’s growth is determined based on distribution channel, product type, and
age group. Based on the distribution channel, it is sectioned into retail,
hospital, and online pharmacies.
Leading
firms in the studied market consist of Novartis International AG, Reckitt
Benckiser Group Plc, Sanofi SA, Pfizer Inc, and The Himalaya Drug Company.
Novartis International AG researches, develops,
and markets healthcare products. Its innovative medicines division provides
patented prescription medications and commercializes products in oncology,
immunology, respiratory, and established medicines. Additionally, its Sandoz
division offers active ingredients and dosages in the areas of cardiovascular,
dermatology, respiratory, gastrointestinal, etc. Novartis has operations across
numerous countries, including the Latin American nations.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the cough syrup market
revenue growth in Latin America and its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the LA cough
syrup market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. LATIN
AMERICA COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE COUGH SYRUP MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
DEMAND FOR HERBAL COUGH SYRUPS
2.2.2. COMPANIES
PROVIDE SUGAR-FREE COUGH SYRUPS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. INCREASING
CHRONIC RESPIRATORY DISEASES
2.7.2. RISE
IN OLDER POPULATION
2.8. MARKET
CHALLENGES
2.8.1. OVERDOSE
RISK
2.8.2. STRICT
GOVERNMENT REGULATIONS AND RESTRICTIONS
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASE
IN CHILD-FRIENDLY COUGH SYRUP FLAVORS
2.9.2. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.9.3. SPECIAL
PEDIATRIC COUGH SYRUPS
3. LATIN
AMERICA COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS/ANTITUSSIVES
3.2. COMBINATION
MEDICATIONS
3.3. EXPECTORANTS
4. LATIN
AMERICA COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP
4.1. ADULT
4.2. PEDIATRIC
5. LATIN
AMERICA COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACY
5.2. HOSPITAL
PHARMACY
5.3. ONLINE
PHARMACY
6. LATIN
AMERICA COUGH SYRUP MARKET – COUNTRY OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ACELLA
PHARMACEUTICALS LLC
7.3. ASTRAZENECA
PLC
7.4. CIPLA
LIMITED
7.5. DABUR
INDIA LTD
7.6. GLAXOSMITHKLINE
7.7. GLENMARK
PHARMACEUTICALS LIMITED
7.8. JOHNSON
AND JOHNSON
7.9. MERCK
KGAA
7.10. NOVARTIS
INTERNATIONAL AG
7.11. PFIZER
INC
7.12. PROCTOR
AND GAMBLE CO
7.13. RECKITT
BENCKISER GROUP PLC
7.14. SANOFI
SA
7.15. THE
HIMALAYA DRUG COMPANY
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA COUGH
SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: THE COUNTRIES WITH
THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020
TABLE 4: LATIN AMERICA COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA COUGH
SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: LATIN AMERICA COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 3: LATIN AMERICA COUGH
SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA COUGH
SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA COUGH
SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA COUGH
SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)
FIGURE 7: LATIN AMERICA COUGH
SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA COUGH
SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNELS, 2021 & 2028 (IN %)
FIGURE 10: LATIN AMERICA COUGH
SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA COUGH
SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA COUGH
SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA COUGH
SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 14: BRAZIL COUGH SYRUP
MARKET 2022-2028 (IN $ MILLION)
FIGURE 15: MEXICO COUGH SYRUP
MARKET 2022-2028 (IN $ MILLION)
FIGURE 16: REST OF LATIN AMERICA
COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)